Caldera Therapeutics, Inc. — Form D
Caldera Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-21. The offering totals $37.5M, of which $37.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-01-21
- Form: D
- Accession: 0002069936-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $37.5M
- Amount sold: $37.5M
- Investors: 3
- Date of first sale: 2026-01-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-570654
Issuer
- Name: Caldera Therapeutics, Inc.
- CIK: 0002069936
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 300 TECHNOLOGY SQUARE, CAMBRIDGE, MA, 02139
- Phone: (781) 254-6624
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Michelle Doig | Director | Cambridge, MA |
| Michael Gladstone | Director | Cambridge, MA |
| Aaron Royston | Director | Cambridge, MA |
| Xiaodi Su | Director | Cambridge, MA |
| Praveen Tipirneni | Director | Cambridge, MA |
| Praveen Tipirneni | Executive Officer | Cambridge, MA |
More